RELEASE: CMS Announces Next 15 Drugs Selected for Medicare Negotiation, Building On Historic Efforts To Lower Drug Prices
Patients For Affordable Drugs Celebrates Another Critical Step Forward in the Fight Against Skyrocketing Prescription Costs
Patients For Affordable Drugs Celebrates Another Critical Step Forward in the Fight Against Skyrocketing Prescription Costs
The Brief Counters Insulin Manufacturer’s Legal Arguments, Recounts The History Of Big Pharma’s Opposition To Medicare Negotiation, And Demonstrates The Program’s Positive Impact On Millions Of Patients
Hello, I am Tonya Nixon and I am a retired registered nurse from Escalon, California.
I am currently a patient living with a seizure disorder that is a residual result from a brain tumor removal surgery.
I am Kathleen Morgan, a retired healthcare professional from Aurora, Colorado, living with high low-density lipoprotein (LDL) cholesterol since 2022.
Hello, my name is Joe Solowiejczyk, and I am a diabetes educator and nurse that has been living with type 1 diabetes, allergies and chronic kidney disease stage 3.
My name is Aarolyn McCullough, a resident of Oak Park, Michigan, a liver transplant survivor, and a patient living with diabetes.
My name is Joshua Swatosh. I am 45 years old and live in Austin, Texas.
I am blind and have epilepsy. I had a left temporal lobectomy in 2015 and have gone from having seizures every 2 weeks to every 6-8 months.
Millions Of Patients Anticipate Substantial Savings As New Limit On Annual Out-of-Pocket Costs Goes Into Effect January 1st
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.